The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Almogran 12.5 mg film-coated tablet

Almirall, S.A.PA0968/001/001

Main Information

Trade NameAlmogran 12.5 mg film-coated tablet
Active SubstancesAlmotriptan
Dosage FormFilm-coated tablet
Licence HolderAlmirall, S.A.
Licence NumberPA0968/001/001

Group Information

ATC CodeN02CC Selective serotonin (5HT1) agonists
N02CC05 almotriptan


License statusAuthorised
Licence Issued27/10/2000
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back